Financhill
Sell
44

BIO Quote, Financials, Valuation and Earnings

Last price:
$328.20
Seasonality move :
8.52%
Day range:
$325.72 - $334.10
52-week range:
$262.12 - $387.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.61x
P/B ratio:
1.22x
Volume:
660.4K
Avg. volume:
204.3K
1-year change:
6.21%
Market cap:
$9.2B
Revenue:
$2.7B
EPS (TTM):
-$27.33

Earnings Data

Next earnings date for BIO
Feb 14
2025
Most recent earnings per share
$23.34
Beat by $22.16
(Oct 30/2024)
Consensus Estimate
$1.18
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/14/2025 Q4 $680.6M -- -- $2.89 --
10/30/2024 Q3 $628.6M $649.7M $23.34 $1.18 $22.16
08/01/2024 Q2 $646.4M $638.5M -$76.26 $2.02 -$78.28
05/07/2024 Q1 $620.1M $610.8M $13.45 $2.14 $11.31
02/15/2024 Q4 $686.6M $681.2M $12.14 $2.87 $9.27
10/26/2023 Q3 -- -- $3.64 $2.81 $0.83
08/03/2023 Q2 -- -- -$39.59 $2.68 -$42.27
05/04/2023 Q1 -- -- $2.32 $3.48 -$1.16
02/16/2023 Q4 -- -- $27.78 $3.44 $24.34
10/27/2022 Q3 -- -- -$5.52 $2.77 -$8.29
07/28/2022 Q2 -- -- -$31.12 $2.77 -$33.89
04/28/2022 Q1 -- -- -$112.57 $3.23 -$115.80
02/10/2022 Q4 -- -- -$52.59 $2.87 -$55.46
10/28/2021 Q3 -- -- $129.96 $2.48 $127.48
07/29/2021 Q2 -- -- $30.32 $2.70 $27.62
04/29/2021 Q1 -- -- $32.38 $2.94 $29.44
02/11/2021 Q4 -- -- $27.81 $3.32 $24.49
10/29/2020 Q3 -- -- $43.64 $1.82 $41.82
07/30/2020 Q2 -- -- $32.15 $1.15 $31.00
05/06/2020 Q1 -- -- $22.72 $1.57 $21.15
02/13/2020 Q4 -- -- $18.31 $2.45 $15.86
10/31/2019 Q3 -- -- -$8.68 $1.41 -$10.09
08/01/2019 Q2 -- -- -- $1.34 --
05/08/2019 Q1 -- -- -- $1.09 --
02/28/2019 Q4 -- -- -- $1.73 --
11/01/2018 Q3 -- -- -- $1.14 --
08/07/2018 Q2 -- -- -- -- --
05/08/2018 Q1 -- -- -- -- --
02/27/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- -- -- --
08/03/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
02/23/2017 Q4 -- -- -- -- --
11/01/2016 Q3 -- -- -- -- --
08/03/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --
11/03/2015 Q3 -- -- -- -- --
08/06/2015 Q2 -- -- -- -- --
05/05/2015 Q1 -- -- -- -- --
02/26/2015 Q4 -- -- -- -- --

Bio-Rad Laboratories Earnings Questions

  • How Much did Bio-Rad Laboratories Generate in Revenue Last Quarter?

    Bio-Rad Laboratories reported $649.7M worth of top line sales in its most recent quarter.

  • Did Bio-Rad Laboratories Beat Earnings Last Quarter?

    Bio-Rad Laboratories announced earnings per share of $23.34 which represents a beat of analyst forecast a $1.18 per share.

  • Is Bio-Rad Laboratories Profitable?

    Bio-Rad Laboratories reported $355.9M that represents $12.72 per share over the last quarter.

  • What is the Analyst Consensus for Bio-Rad Laboratories EPS Next Year?

    Bio-Rad Laboratories's earnings are forecast to grow from -$21.82 per share to $11.54 per share next year representing an increase of --.

  • When is Bio-Rad Laboratories's Earnings Date?

    Bio-Rad Laboratories's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.65% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.9% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock